Tüdőrák: vizsgálatok itt: Spanyolország
275 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 17.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 248 worldwide
- Run by
- Terremoto Biosciences Inc.
See details and how to joinNCT07109726 - 1/2. fázisTaking peopleStudy to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Where
- A Coruña, Alicante, Barcelona, Málaga, Santander, Sevilla
- Életkor
- 18 év and over
- People
- 252 worldwide
- Run by
- AbbVie
See details and how to joinNCT06772623 · EU 2024-514465-18-00 - 3. fázisTaking peopleA Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
- Where
- A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Palma, Santiago de Compostela, Sevilla, Valencia, Vigo
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- Mirati Therapeutics Inc.
See details and how to joinNCT06875310 · EU 2024-515698-85-00 - 2. fázisTaking peopleA Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
- Where
- A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- AbbVie
See details and how to joinNCT07155174 · EU 2024-517490-24-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Barcelona, Madrid, Málaga, Seville, Valencia
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 2. fázisTaking peopleTrial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
- Where
- Barcelona, Girona, Jaén, Logrono, Lugo, Madrid, Málaga, Pamplona, Santiago de Compostela, Sevilla
- Életkor
- 18 év and over
- People
- 131 worldwide
- Run by
- CatalYm GmbH
See details and how to joinNCT07246863 · EU 2024-516794-70-00 - 3. fázisTaking peopleA phase 3 trial comparing a therapeutic cancer vaccine OSE2101 to chemotherapy docetaxel in patients with metastatic Non-Small Cell Lung Cancer (NSCLC) after immunotherapy failure.
- Where
- A Coruña, Badalona, Barakaldo, Barcelona, Córdoba, Girona, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Lugo, Madrid, Majadahonda, Málaga, Marbella, Palma, Sevilla
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- OSE Immunotherapeutics
See details and how to join2023-509340-10-00 - 2. fázisTaking peoplePhase 2 Study Evaluating the Safety and Efficacy of Neoadjuvant Amivantamab in Combination with Lazertinib or Chemotherapy in Resectable EGFR-Mutated Non-Small Cell Lung Cancer
- Where
- Alicante, Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 6
- Run by
- Janssen Cilag International
See details and how to join2025-524816-13-00 - 3. fázisTaking peopleStudy of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
- Where
- A Coruña, Barcelona, Burgos, Castello De La Plana, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Lugo, Madrid, Málaga, Oviedo, Santiago de Compostela, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 686 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06899126 · EU 2024-515658-26-00 - 1. fázisTaking peopleA Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
- Where
- Barcelona, Madrid, Málaga
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07140016 · EU 2025-522398-12-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- Where
- Barakaldo, Barcelona, Jaén, Madrid, Málaga, Murcia
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07361510 · EU 2025-523586-18-00 - 2. fázisTaking peopleA Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Where
- Badalona, Barcelona, Madrid, Majadahonda, Málaga, Sevilla
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07680764 · EU 2026-525170-19-00 - 1. fázisNot yet taking people in SpanyolországA phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
- Where
- Barcelona, L'Hospitalet de Llobregat, Madrid
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-518348-19-00 - 2. fázisTaking peopleNeoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Where
- A Coruña, Alicante, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Reus, Sevilla, Terrassa, Valencia
- Életkor
- 18 év to 95 év
- People
- 630 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05061550 · EU 2023-508852-21-00 - No phaseTaking peopleTelerehabilitation Exercise Program for Postoperative Recovery in Lung Cancer.
- Where
- Seville
- Életkor
- 18 év to 80 év
- People
- 56
- Run by
- University of Seville
See details and how to joinNCT07861282 - 3. fázisTaking peopleStudy of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
- Where
- A Coruña, Barcelona, Córdoba, Girona, Jaén, Las Palmas de Gran Canaria, Madrid, Málaga, Seville, Valencia
- Életkor
- 18 év and over
- People
- 695 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06801834 - 3. fázisTaking peopleA Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer
- Where
- Badajoz, Badalona, Barcelona, Elche, Girona, Jerez de la Frontera, Lleida, Madrid, Majadahonda, Málaga, Oviedo, Pamplona, Reus, Sevilla, Torrejón de Ardoz, Valencia
- Életkor
- 18 év and over
- People
- 263 worldwide
- Run by
- Zai Lab (US) LLC
See details and how to join2025-522818-23-00 - 1/2. fázisTaking peopleStudy of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Where
- A Coruña, Barcelona, Madrid, Málaga, Pamplona, Pozuelo de Alarcón, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 616 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06162221 · EU 2025-521147-21-00 - 2. fázisTaking peopleTrial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
- Where
- Barcelona, Girona, Jaén, Lugo, Madrid, Málaga, Pamplona, Rioja, Santander, Santiago de Compostela, Seville
- Életkor
- 18 év and over
- People
- 107 worldwide
- Run by
- CatalYm GmbH
See details and how to joinNCT07098988 · EU 2024-516792-32-01 - No phaseTaking peoplePRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
- Where
- Badajoz, Las Palmas de Gran Canaria, Majadahonda
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04790253 - 1. fázisTaking peopleA Study of ZL-1310 in Subjects With Small Cell Lung Cancer
- Where
- Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Seville, Valencia
- Életkor
- 18 év and over
- People
- 339 worldwide
- Run by
- Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT06179069 - 2. fázisFut, nem toborozA Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
- Where
- Barcelona, L'Hospitalet de Llobregat, Pozuelo de Alarcón
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06731907 · EU 2024-515772-12-00 - 3. fázisTaking peopleA Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Where
- Barcelona, Elche, Girona, Jerez de la Frontera, Madrid, Málaga, Pamplona, Reus, Seville, Valencia
- Életkor
- 18 év and over
- People
- 480 worldwide
- Run by
- Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT07218146 - No phaseTaking peopleMultimodal Prehabilitation in Patients With Lung Cancer Undergoing Neoadjuvant Therapy
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 60
- Run by
- Hospital Clinic of Barcelona
See details and how to joinNCT05636969 - 2. fázisTaking peopleA Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
- Where
- A Coruña, Madrid, Málaga, Manresa, Santander, Valencia
- Életkor
- 18 év and over
- People
- 278 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07098338 · EU 2025-524843-11-00